Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary F Hebert

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Life Sciences|March 31, 2023
Plasma hydrogen sulfide, nitric oxide, and thiocyanate levels are lower during pregnancy compared to postpartum in a cohort of women from the Pacific northwest of the United StatesMaxwell B Zeigler, Emily E Fay, Sue L Moreni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 24, 2010
CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearanceAdam J Claessens, Linda J Risler, Sara Eyal, et al.
Life Sciences|October 18, 2020
Changes in erythrocyte membrane epoxyeicosatrienoic, dihydroxyeicosatrienoic, and hydroxyeicosatetraenoic acids during pregnancySelina T Somani, Maxwell Zeigler, Emily E Fay, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 2013
Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancyNora Lee, Mary F Hebert, Bhagwat Prasad, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 4, 2008
Profiling gene expression in human placentae of different gestational ages: an OPRU Network and UW SCOR StudyAndrei M Mikheev, Tomohiro Nabekura, Amal Kaddoumi, et al.
British Journal of Clinical Pharmacology|March 29, 2012
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometricsJ G Coen van Hasselt, Marilee A Andrew, Mary F Hebert, et al.
Pharmacoepidemiology and Drug Safety|March 1, 2018
Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative doseKristin Palmsten, Matthieu Rolland, Mary F Hebert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2006
Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitroYang Dai, Mary F Hebert, Nina Isoherranen, et al.
Molecular Pharmacology|July 18, 2018
Organic Cation Transporter 3 Facilitates Fetal Exposure to Metformin during PregnancyNora Lee, Mary F Hebert, David J Wagner, et al.
Pharmacotherapy|July 5, 2016
Ondansetron Exposure Changes in a Pregnant WomanLara S Lemon, Hongfei Zhang, Mary F Hebert, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Life Sciences|March 31, 2023
Plasma hydrogen sulfide, nitric oxide, and thiocyanate levels are lower during pregnancy compared to postpartum in a cohort of women from the Pacific northwest of the United StatesMaxwell B Zeigler, Emily E Fay, Sue L Moreni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 24, 2010
CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearanceAdam J Claessens, Linda J Risler, Sara Eyal, et al.
Life Sciences|October 18, 2020
Changes in erythrocyte membrane epoxyeicosatrienoic, dihydroxyeicosatrienoic, and hydroxyeicosatetraenoic acids during pregnancySelina T Somani, Maxwell Zeigler, Emily E Fay, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 2013
Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancyNora Lee, Mary F Hebert, Bhagwat Prasad, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 4, 2008
Profiling gene expression in human placentae of different gestational ages: an OPRU Network and UW SCOR StudyAndrei M Mikheev, Tomohiro Nabekura, Amal Kaddoumi, et al.
British Journal of Clinical Pharmacology|March 29, 2012
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometricsJ G Coen van Hasselt, Marilee A Andrew, Mary F Hebert, et al.
Pharmacoepidemiology and Drug Safety|March 1, 2018
Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative doseKristin Palmsten, Matthieu Rolland, Mary F Hebert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2006
Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitroYang Dai, Mary F Hebert, Nina Isoherranen, et al.
Molecular Pharmacology|July 18, 2018
Organic Cation Transporter 3 Facilitates Fetal Exposure to Metformin during PregnancyNora Lee, Mary F Hebert, David J Wagner, et al.
Pharmacotherapy|July 5, 2016
Ondansetron Exposure Changes in a Pregnant WomanLara S Lemon, Hongfei Zhang, Mary F Hebert, et al.
Pageof 9